Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors.


Journal

American journal of ophthalmology
ISSN: 1879-1891
Titre abrégé: Am J Ophthalmol
Pays: United States
ID NLM: 0370500

Informations de publication

Date de publication:
10 2020
Historique:
received: 09 11 2019
revised: 23 05 2020
accepted: 18 06 2020
pubmed: 6 7 2020
medline: 21 11 2020
entrez: 5 7 2020
Statut: ppublish

Résumé

This study evaluated the risk and risk factors for exudative retinal detachment (ERD) in ocular inflammatory diseases. Retrospective cohort study. Patients with noninfectious ocular inflammation had been followed longitudinally between 1978 and 2007 at 4 US subspecialty uveitis centers. The main outcome measurements were occurrences of ERD and predictive factors. A total of 176 of 14,612 eyes with ocular inflammation presented with ERD. Among uveitis cases, Vogt-Koyanagi-Harada syndrome (VKH) (odds ratio [OR] = 109), undifferentiated choroiditis (OR = 9.18), sympathetic ophthalmia (OR = 8.43), primary or secondary panuveitis (OR = 7.09), multifocal choroiditis with panuveitis (OR = 4.51), and "other" forms of posterior uveitis (OR = 16.9) were associated with a higher prevalence of ERD. Among the 9,209 uveitic or scleritic eyes initially free of ERD and followed, 137 incident ERD cases were observed over 28,949 eye-years at risk (incidence rate = 0.47% [0.40%-0.56%/eye-year]). VKH (HR = 13.2), sympathetic ophthalmia (HR = 5.82), undifferentiated choroiditis (HR = 6.03), primary or secondary panuveitis (HR = 4.21), and rheumatoid arthritis (HR = 3.30) were significantly associated with incident ERD. A significant dose-response relationship with the prevalence and incidence of ERD were observed for AC cells and vitreous cell activity. African Americans had significantly higher prevalence and incidence of ERD. Other ocular inflammatory conditions in addition to VKH syndrome and posterior scleritis were associated with increased risk of ERD, indicating that ERD does not necessarily dictate a diagnosis of VKH or posterior scleritis. In addition, the relationship between ERD and inflammatory severity factors implies that inflammation is a key predictive factor associated with developing ERD and requires early and vigorous control.

Identifiants

pubmed: 32621891
pii: S0002-9394(20)30315-9
doi: 10.1016/j.ajo.2020.06.019
pmc: PMC7529966
mid: NIHMS1608696
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-287

Subventions

Organisme : NEI NIH HHS
ID : R01 EY014943
Pays : United States
Organisme : NEI NIH HHS
ID : R21 EY026717
Pays : United States
Organisme : NEI NIH HHS
ID : R56 EY014943
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Feb;113(2):172-6
pubmed: 22677732
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Ophthalmology. 2010 Mar;117(3):591-9, 599.e1
pubmed: 20036008
Ophthalmology. 1999 Dec;106(12):2380-6
pubmed: 10599675
Int Ophthalmol Clin. 1998 Winter;38(1):177-95
pubmed: 9532481
Br J Ophthalmol. 2010 Jul;94(7):848-53
pubmed: 20606023
Ophthalmology. 1980 Feb;87(2):109-21
pubmed: 7383540
Curr Opin Ophthalmol. 2010 Nov;21(6):430-5
pubmed: 20829689
Acta Ophthalmol. 2011 Jun;89(4):e357-66
pubmed: 21251241
Medicine (Baltimore). 2001 Jul;80(4):263-70
pubmed: 11470987
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):316-20
pubmed: 21958181
Am J Ophthalmol. 1987 Feb 15;103(2):234-5
pubmed: 3812627
Ophthalmology. 2009 Sep;116(9):1799-807
pubmed: 19643489
Korean J Ophthalmol. 2009 Jun;23(2):74-9
pubmed: 19568354
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):312-5
pubmed: 21958180
Int Ophthalmol. 2007 Apr-Jun;27(2-3):81-5
pubmed: 17435969
Surv Ophthalmol. 1988 Mar-Apr;32(5):297-316
pubmed: 3043740
Eye (Lond). 2009 Jun;23(6):1475-7
pubmed: 18617904
N Engl J Med. 2007 Nov 22;357(21):2189-94
pubmed: 18032770
Br J Ophthalmol. 1996 Apr;80(4):332-6
pubmed: 8703885
Int Ophthalmol. 1990 Oct;14(5-6):303-8
pubmed: 2249907
Int Ophthalmol. 1982 Feb;4(3):129-35
pubmed: 7068330
Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55
pubmed: 18300089
Am J Ophthalmol. 2009 Oct;148(4):500-509.e2
pubmed: 19570522

Auteurs

Deepika N Shah (DN)

Eye Doctors of Washington, Washington, DC, USA; Department of Ophthalmology, Georgetown University, Washington, DC, USA.

Ahmad Al-Moujahed (A)

Department of Ophthalmology, Byers Eye Institute, Stanford University School of Medicine, Palo Alto, California, USA.

Craig W Newcomb (CW)

Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

R Oktay Kaçmaz (RO)

Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA; Mallinckrodt Pharmaceuticals, Bedminster, New Jersey, USA.

Ebenezer Daniel (E)

Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Jennifer E Thorne (JE)

Department of Ophthalmology, Wilmer Eye Institute, the Departments of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Epidemiology, Center for Clinical Trials and Evidence Synthesis, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

C Stephen Foster (CS)

Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA.

Douglas A Jabs (DA)

Department of Ophthalmology, Wilmer Eye Institute, the Departments of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Epidemiology, Center for Clinical Trials and Evidence Synthesis, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.

Grace A Levy-Clarke (GA)

Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA.

Robert B Nussenblatt (RB)

Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA.

James T Rosenbaum (JT)

Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA; Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; Legacy Devers Eye Institute, Portland, Oregon, USA.

H Nida Sen (HN)

Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA.

Eric B Suhler (EB)

Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon, USA; Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA; Portland Veterans' Affairs Medical Center, Portland, Oregon, USA.

Nirali P Bhatt (NP)

Department of Ophthalmology, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

John H Kempen (JH)

Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA; Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, USA; Myung Sung Christian Medical Center Eye Unit, Myung Sung General Hospital and Myung Sung Medical School, Addis Ababa, Ethiopia. Electronic address: john_kempen@meei.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH